Bridging Specialties™: Timely Diagnosis for ILD
Bridging Specialties™: Timely Diagnosis for ILD empowers healthcare professionals to provide timely diagnosis for patients with interstitial lung disease (ILD). By providing practical information and tools to help healthcare professionals recognize the signs and symptoms of ILD and understand the diagnostic process, patients can be diagnosed earlier and experience better disease management and quality of life.
This program consists of two learning activities:
Bridging Specialties™: Early Detection for ILD
Enhance your recognition and awareness of ILDs to shorten the time to diagnosis for your patients.
Bridging Specialties™: ILD Decision-Making Tool
Conduct a simulated visit with patients and choose which clinical actions to take based on presentation.
Visit the CHEST website to access the Bridging Specialties™: ILD Clinician Toolkit containing additional resources focused on the steps to take when a patient displays signs of ILD. From an ILD-specific patient questionnaire, to a decision-making tool that walks you through patient scenarios, and much more, this toolkit can help you reach an earlier diagnosis and start treatment for your patients more quickly—since time lost is lung lost.
September 14, 2023
September 14, 2024
This activity is provided by American College of Chest Physicians in partnership with Three Lakes Foundation.
- Physicians — maximum of 0.5 AMA PRA Category 1 Credit™
- Nurses — 0.5 Nursing Contact Hour
- Nurse Practitioners — AANPCB accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME. Check with the AANPCB for further guidelines.
- Physician Assistants — 0.5 Category 1 credit
All other healthcare professionals completing this course will be issued a statement of participation.
This activity is designed to meet the educational needs of primary care physicians, community pulmonologists, geriatricians, rhuematologists, and advance practice providers.
Early Detection for ILD
Enhance your recognition and awareness of the signs and symptoms of ILDs so you're able to shorten the time to diagnosis for your patients. Understand reasons for delayed diagnosis, symptoms to watch and listen for, suggested patient workups, and proactive steps to take—including when you may want to refer to an ILD specialist.
ILD Decision-Making Tool
Participate in interactive scenarios to conduct a simulated visit with patients and choose a clinical action to take, including completing a physical exam, ordering tests, referring to an ILD specialist, or providing treatment.
Upon completion of this activity, participants should be better able to:
- Identify the classic symptoms of ILDs.
- Describe how patient history, ILD-specific questionnaires, and additional workups impact early detection in adults with suspected ILD.
- Recognize how early suspicion of ILD and detection benefits patients receiving treatment options earlier through partnerships with an ILD specialist.
Jessica Glennie, APRN, MSN
Interstitial Lung Disease Clinic
William Lago, MD
Family Medicine Physician
Wooster Family Health Center
Cleveland Clinic Foundation
Anoop M. Nambiar, MD, MS, FCCP
Center for Interstitial Lung Diseases
University of Texas Health Science Center at San Antonio
Mary Beth Scholand, MD, FCCP
Interstitial Lung Disease Clinic
University of Utah
Salt Lake City
The American College of Chest Physicians is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Physician Credit Designation
The American College of Chest Physicians is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The American College of Chest Physicians designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Credit Designation
Provider approved by the California Board of Registered Nursing, Provider Number 16433, for 0.5 contact hour.
The American Academy of Nurse Practitioners Certification Board (AANPCB) accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME. Individuals are responsible for checking with the AANPCB for further guidelines.
American Academy of Physician Assistants (AAPA) accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. PAs may receive a maximum of 0.5 Category 1 credit for completing this activity.
Maintenance of Certification Statement
Successful completion of this CME activity enables the participant to earn up to 0.5 MOC Part 2 Medical Knowledge points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC points. Upon successful completion of this course, CHEST will submit your completion data to ABIM via ACCME's Program and Activity Reporting System (PARS) for MOC points. Please allow 3-5 business days after claiming for points to be reflected on your ABIM record. The participation threshold or passing standard for this activity is learner completion of the module, “Early Detection of ILD”, the module, post-assessment with a 70% passing score, “Decision-Making Tool”, and completion of the activity evaluation documenting expected changes in practice.
Disclosures of Conflicts of Interest
The mission and vision of CHEST include our commitment to provide accredited continuing education based on current science and clinical reasoning, while giving a fair and balanced view of diagnostic and therapeutic options. All scientific research referred to, reported, or used in CHEST- accredited education in support or justification of a patient care recommendation is expected to conform to the generally accepted standards of experimental design, data collection, analysis, and interpretation. CHEST does not promote recommendations, treatment, or manners of practicing healthcare that are determined to have risks or dangers that outweigh the benefits or are known to be ineffective in the treatment of patients.
To guarantee our accredited continuing education is independent, we require all planners, faculty, and others in control of educational content to provide disclosures of any financial relationships within the prior 24 months with ineligible companies as defined by the ACCME Standards for Integrity and Independence in Accredited Continuing Education
The following faculty members of this activity have disclosed to CHEST that they have a relevant financial relationship with a commercial interest as it relates to the activity:
- Jessica Glennie, APRN, MSN
- Boehringer Ingelheim, United Therapeutics Corporation
- Anoop M. Nambiar, MD, MS, FCCP
- Boehringer Ingelheim; Genentech, a member of the Roche Group; Veracyte
- Mary Beth Scholand, MD, FCCP
- Boehringer Ingelheim; Genentech, a member of the Roche Group; United Therapeutics Corporation; Veracyte
The following faculty members of this activity have indicated to CHEST that they have no relevant financial relationships with any commercial interests:
William Lago, MD—Nothing to Disclose
Instructions for Participation and Credit
The participation threshold or passing standard for this activity is learner completion of the module, “Early Detection of ILD”, the module, post-assessment with a 70% passing score, “Decision-Making Tool”, and completion of the activity evaluation documenting expected changes in practice.
There are no fees for participating and receiving CME credit for this enduring activity. To receive CME credit participants must:
- Read the CME/CE information and faculty disclosures.
- Participate in the online activity.
- Submit the evaluation form.
Certificates will be emailed to the participant.
Course Viewing Requirements
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above
Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above
The American College of Chest Physicians (“CHEST”) and its officers, regents, executive committee members, members, related entities, employees, representatives and other agents (collectively, “CHEST Parties”) are not responsible in any capacity for, do not warrant and expressly disclaim all liability for, any content whatsoever in any CHEST publication or other product (in any medium) and the use or reliance on any such content, all such responsibility being solely that of the authors or the advertisers, as the case may be. By way of example, without limiting the foregoing, this disclaimer of liability applies to the accuracy, completeness, effectiveness, quality, appearance, ideas, or products, as the case may be, of or resulting from any statements, references, articles, positions, claimed diagnosis, claimed possible treatments, services, or advertising, express or implied, contained in any CHEST publication or other product. Furthermore, the content should not be considered medical advice and is not intended to replace consultation with a qualified medical professional. Under no circumstances, including negligence, shall any of CHEST Parties be liable for any DIRECT, INDIRECT, INCIDENTAL, SPECIAL or CONSEQUENTIAL DAMAGES, or LOST PROFITS that result from any of the foregoing, regardless of legal theory and whether or not claimant was advised of the possibility of such damages.
If you need help, contact CMEsupport@chestnet.org.